Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

Background. Angiotensin-converting enzyme (ACE) inhibitors have been shown to improve outcome in patients with renal failure not on dialysis therapy and patients on haemodialysis (HD). However, their effect on survival has not been studied in peritoneal dialysis (PD) patients. The present study exam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2008-11, Vol.23 (11), p.3704-3710
Hauptverfasser:	Fang, Wei, Oreopoulos, Dimitrios G., Bargman, Joanne M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy angiotensin II type 1 receptor blockers (ARB) Angiotensin II Type 1 Receptor Blockers - therapeutic use angiotensin-converting enzyme (ACE) inhibitors Angiotensin-Converting Enzyme Inhibitors - therapeutic use Biological and medical sciences Blood Pressure - physiology Emergency and intensive care: renal failure. Dialysis management end-stage renal disease (ESRD) Female Glomerulonephritis Humans Hypertension - drug therapy Hypertension - physiopathology Intensive care medicine Kaplan-Meier Estimate Kidney Failure, Chronic - mortality Kidney Failure, Chronic - physiopathology Kidney Failure, Chronic - therapy Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Peritoneal Dialysis peritoneal dialysis (PD) Regression Analysis Retrospective Studies survival Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!